1. Home
  2. TNYA vs QSI Comparison

TNYA vs QSI Comparison

Compare TNYA & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.80

Market Cap

181.5M

Sector

Health Care

ML Signal

HOLD

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.82

Market Cap

191.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNYA
QSI
Founded
2016
2013
Country
United States
United States
Employees
N/A
145
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
181.5M
191.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TNYA
QSI
Price
$0.80
$0.82
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$5.33
$1.00
AVG Volume (30 Days)
2.7M
4.9M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
54.96
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$618.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.69
52 Week High
$2.35
$3.10

Technical Indicators

Market Signals
Indicator
TNYA
QSI
Relative Strength Index (RSI) 50.07 38.01
Support Level $0.65 $0.69
Resistance Level $0.80 $1.04
Average True Range (ATR) 0.07 0.05
MACD 0.00 -0.01
Stochastic Oscillator 39.32 9.23

Price Performance

Historical Comparison
TNYA
QSI

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: